Infectious Disease and Pathogenesis Track
PLEASE NOTE: THE IBS Program is no longer accepting students. Students interested in the IBS program should apply through the new Graduate Program in Interdisciplinary Biomedical Sciences. The Clinical and Translational Sciences track listed below has not changed. These pages were left for those students who were accepted into the IBS program before Fall 2016.
Track Leader-Dr. Karl Boehme
Kathleen Eisenach, Ph.D. (Pathology)
Tuberculosis diagnostics, molecular epidemiology of TB, surrogate markers of response to TB therapy, and differential pathogenesis of clinical TB strains.
Dana Gaddy, Ph.D. (Physiology and Biophysics) Web profile
Our laboratory focuses on the endocrine, cellular and molecular mechanisms that govern the maintenance of the musculoskeletal system, with particular focus on the normal and pathophysiological changes associated with age, disuse, menopause, and metastatic disease.
Usha Ponnappan, Ph.D. (Microbiology and Immunology) Web profile
Our research is focused on understanding the role of ubiquitin proteasome pathway in transcriptional regulation, immune signaling and in the induction and regulation of transcription factor NF kappa B in innate and adaptive immunity. Additionally, our efforts are directed at dissecting the role of redox regulation in immune senescence and inflammation.
Lee S.F. Soderberg, Ph.D. (Microbiology and Immunology) Web profile
Certain toxic compounds suppress immunity by modulating signal transduction and proteasome function and result in increased tumor growth.
Xuming Zhang, Ph.D. (Microbiology and Immunology) Web profile
To elucidate the mechanisms and regulation of coronavirus RNA synthesis, the molecular pathogenesis of coronavirus-induced neurodegenerative diseases, and virus-host cell interactions.